FBInvestor
Stocks / Anixa Biosciences Inc
Institutional Ownership

Anixa Biosciences Inc

CUSIP 03528H109COMANIXQ1 2026

13D / 13G Filings
8
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
16.3%
Max % of class reported
Institutional Holders
57
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

8 filings · latest Jan 6, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jan 6, 2026Michael Catelani13D/A7.0%SEC
2Jun 6, 2025Amit Kumar13D/A16.3%SEC
3Jan 3, 2025Amit Kumar13D/A15.1%SEC
4May 3, 2024Catelani Michael13D5.3%1.76MSEC
5Jan 16, 2024Kumar Amit13D/A13.5%4.88MSEC
6Sep 3, 2021Kumar Amit13D/A10.3%3.42MSEC
7Jun 10, 2021Kumar Amit13D/A8.6%2.80MSEC
8Feb 5, 2021Titterton Lewis H Jr13D/A5.4%1.45MSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Laird Norton Wetherby Trust Company, LLC566.3K$1.46M
2Ubs Group AG551.6K$1.42M
3D.A. Davidson & Co.539.3K$1.39M
4Geode Capital Management, LLC364.7K$941.4K
5Marshall Wace, LLP173.2K$446.8K
6Blackrock, Inc.170.1K$438.9K
7State Street Corp159.0K$410.3K
8Susquehanna International Group, LLP99.5K$256.6K
9Lpl Financial LLC81.0K$208.9K
10Northern Trust Corp66.8K$172.4K